ISCTX | NRGEX | ISCTX / NRGEX | |
Total Expense Ratio | 1.33 | 0.03 | 4,433% |
Annual Report Gross Expense Ratio | 1.46 | 0.69 | 212% |
Fund Existence | 17 years | 4 years | - |
Gain YTD | 8.956 | -3.342 | -268% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 170M | 8.69B | 2% |
Annual Yield % from dividends | 1.95 | 0.54 | 362% |
Returns for 1 year | 5.02 | -9.46 | -53% |
Returns for 3 years | 56.04 | 8.17 | 686% |
Returns for 5 years | -1.69 | N/A | - |
Returns for 10 years | -11.39 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
JFNIX | 75.85 | 0.47 | +0.62% |
Janus Henderson Global Life Sciences I | |||
HRLVX | 22.93 | 0.13 | +0.57% |
Harbor Large Cap Value Admin | |||
HADUX | 79.12 | 0.41 | +0.52% |
Horizon Equity Premium Income Advisor | |||
VLLIX | 49.30 | 0.06 | +0.12% |
Value Line Larger Companies Focus Instl | |||
CLBEX | 38.90 | 0.04 | +0.10% |
American Funds American Balanced 529E |